|
|
Latest Headlines
Xcelience and IriSys business alliance agreement strengthens regional access to CMC/Regulatory expertise
 More...
| Xcelience Adds Piccola B10 Minipress for GMP Tablet Formulation Development in Experimental Area
More...
| Xcelience and Penn Pharma Form a Joint Venture to Provide API Into Capsule Services in Europe and Asia Pacific Markets
More...
|
|
|
|
|
|
|
Xcelience in Print
|
|
|
|
|
 | | July 2010, "It All Starts With The API": Suzanne Elvidge for Life Science Leader, featuring a Case Study for Chemistry Playbook | |
| | July 2010, "Environmentally Friendly Strategies for CMOs, CROs": Chris MacKinnon for Life Science Leader | |
| | June 2, 2010, "Outsourcing Clinical Trial Development and Materials": Patricia Van Arnum, Pharmaceutical Technology, Volume 6, Issue 34, pp 44-46 | |
| | April 12, 2010, "Xcelience plans to hire seven, bucks layoff trend": Xcelience LLC said it would be adding to its staff at its Tampa headquarters. | |
| | March 5, 2010, "Four contractors team for drug development", George Miller: An alliance among four service providers aims to ease project management and to smooth hand-offs between drugmakers and contractors throughout the various stages of drug development. | |
| | November 15, 2009 (Vol. 29, No. 20) – “Head Start Boosts Value of Stability Testing; Early Data Can Guide Formulation Strategies and Contribute to Regulatory Findings”. Author: Vicki Glaser.: This article features quotes by James B. Clark, Team Leader, Pharmaceutical Development Services. “Early stability data can help distinguish between parallel compounds in development, guide formulation strategies, contribute to regulatory filings for early-stage clinical studies, and allow researchers “to go into Phase II or III trials with a lot more confidence,” said Clark. | |
| | November 2009, “Head Start Boosts Value of Stability Testing". Glaser, Vicki (James Clark quoted): Genetic Engineering & Biotechnology News | |
| | November 2009,“Trust, Outsourcing’s Strategic Advantage”. Black-Washington, Kim: Pharma Manufacturing | |
| | October 2009, “The New World: Life After the Great Recession”. Hennecke, Derek: Drug Delivery Technology | |
| | September 2009, “Quality by Design Gets Mixed Reception From Industry”: Tulsi, Bernard (Paul Skultety quoted). Life Science Leader | |
| | July/August 2009, “David vs. Goliath: Why the Little Guys Have All the Advantages”. Hennecke, Derek: Drug Delivery Technology | |
| | July 2009, “Excipient Selection: A Glimpse of Where Excipient Selection is Headed”. Kadri, Balaji V.: Tablets & Capsules | |
| | June 2009, “Formulation Development Options To The Clinic”. Skultety, Paul F., PhD: Contract Pharma | |
| | June 2009, “The Superhero Complex". Hennecke, Derek: Drug Delivery Technology | |
| | June 2009, “Formulation Development: Changing Tides in Formulation Outsourcing Contributors”. Dubin, Cindy (Derek Hennecke and Paul Skultety contributed): Specialty Pharma | |
| | June 2009, Volume 9, Number 6, Specialty Pharma, "Formulation Development: Changing Tides In Formulation Outsourcing", by Cindy H. Dubin, Contributor: This article features a Q&A with Derek Hennecke, CEO & President, and Paul Skultety, Director, Pharmaceutical Development Services. Xcelience, LLC is featured alongside Catalent Pharma Solutions and Metrics, Inc. | |
| | May 2009, “API Characterization Services: Does Your Molecule Need Tutoring?”. Hennecke, Derek: Drug Delivery Technology | |
| | April 2009, “Growth or Recession; Selling Solutions is the Answer”. Hennecke, Derek: Drug Delivery Technology | |
| | March 2009, “Analytical Laboratories Outlook: Analytical Labs In the Pharma Industry: Where do they Stand?”. Dubin, Cindy (Robin Ciupidro contributed): Specialty Pharma | |
| | March 2009, “Formulation | Match.pharm”. Kadri, Balaji V.: Pharmaceutical Formulation & Quality | |
| | August 2008, “Recent Options for Phase I Formulation Development and Clinical Trial Supply”. Kadri, Balaji V.: Pharmaceutical Technology | |
| | April 2008, “Creating Global Clinical Connections”. Robinson, Robin (Randall Guthrie quoted): PharmaVoice | |
Regional Publications
Regional Publications
|
|
|
|
|